Azenta is a medical - instruments & supplies company in the healthcare sector trading on NASDAQ, led by CEO John Marotta, with a market cap of $1.3B.
Upcoming earnings announcement for Azenta
Past 12 earnings reports for Azenta
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 4, 2026 | Q1 2026 | $0.09Est: $0.12 | -25.0% | $148.6MEst: $147.2M | +1.0% | |
| Nov 21, 2025 | Q4 2025 | $0.21Est: $0.20 | +5.0% | $159.2MEst: $156.5M | +1.7% | |
| Aug 5, 2025 | Q3 2025 | $0.19Est: $0.13 | +46.2% | $144.0MEst: $149.7M | -3.8% | |
| May 7, 2025 | Q2 2025 | $0.05Est: $0.08 | -37.5% | $143.0MEst: $140.9M | +1.5% | |
| Feb 5, 2025 | Q1 2025 | $0.08Est: $0.06 | +33.3% | $147.5MEst: $146.0M | +1.1% | |
| Nov 12, 2024 | Q4 2024 | $0.18Est: $0.10 | +80.0% | $170.1MEst: $169.6M | +0.3% | |
| Aug 6, 2024 | Q3 2024 | $0.16Est: $0.08 | +100.0% | $172.8MEst: $165.9M | +4.2% | |
| May 8, 2024 | Q2 2024 | $0.05Est: $0.02 | +150.0% | $159.1MEst: $159.8M | -0.4% | |
| Feb 7, 2024 | Q1 2024 | $0.02Est: -$0.03 | +166.7% | $154.3MEst: $150.7M | +2.4% | |
| Nov 13, 2023 | Q4 2023 | $0.13Est: $0.02 | +550.0% | $172.4MEst: $163.7M | +5.3% | — |
| Aug 8, 2023 | Q3 2023 | $0.13Est: -$0.02 | +750.0% | $165.9MEst: $153.5M | +8.1% | |
| May 9, 2023 | Q2 2023 | -$0.06Est: -$0.02 | -200.0% | $148.4MEst: $161.9M | -8.3% | — |
We use cookies for analytics. See our Privacy and Cookie Policy.